Benoit Chassaing1, Ruth E Ley2, Andrew T Gewirtz3. 1. Institute for Biomedical Sciences, Center for Inflammation, Immunity & Infection, Georgia State University, Atlanta, Georgia. 2. Departments of Microbiology and Molecular Biology & Genetics, Cornell University, Ithaca, New York. 3. Institute for Biomedical Sciences, Center for Inflammation, Immunity & Infection, Georgia State University, Atlanta, Georgia. Electronic address: agewirtz@gsu.edu.
Abstract
BACKGROUND & AIMS: Mice lacking the receptor Toll-like receptor 5 (TLR5-null mice), which recognizes flagellin, have an altered intestinal microbiota composition compared with wild-type mice; they develop low-grade inflammation and metabolic syndrome and are prone to colitis. The relative roles of intestinal epithelial cell (IEC) vs dendritic cell (DC) TLR5 in mediating these phenotypes are not clear; modification of intestinal microbiota composition has been reported to reflect animal husbandry practices rather than loss of TLR5. We generated mice with specific disruption of Tlr5 in IECs or DCs by using a breeding scheme that allows comparison with cohoused siblings as controls. METHODS: We generated C57BL/6 mice with LoxP sites flanking Tlr5. These mice were crossed with mice expressing Cre recombinase, regulated by the villin or CD11c promoters, to generate mice that lacked expression of TLR5 by IECs (TLR5(ΔIEC)) or DCs (TLR5(ΔDC)), respectively. Tlr5(fl/fl) siblings were used as controls. On weaning, mice were housed by sex and genotype or by sex only (genotypes cohoused). Mice were examined for basal phenotypes, including microbiota composition; we also analyzed responses to pathobiont challenge, administration of dextran sodium sulfate, and high-fat diets. RESULTS: Similar to previous findings from TLR5-null mice, TLR5(ΔIEC) mice had low-grade inflammation (mild splenomegaly, shortened colons, and increased fecal levels of lipocalin 2), metabolic syndrome, and an inability to clear pathobionts and were prone to developing colitis compared with their sibling controls under both housing conditions. Development of this inflammation in the TLR5(ΔIEC) mice was eliminated by administration of antibiotics and associated with alterations in localization of microbiota and levels of fecal lipopolysaccharide and flagellin. The composition of the microbiota clustered more closely according to genotype than housing. Loss of TLR5 from DCs did not associate with development of inflammation-associated phenotypes or alterations in the composition of the microbiota but resulted in complete loss of flagellin-induced production of interleukin-22. CONCLUSIONS: In mice, flagellin activation of TLR5 on DCs leads to production of interleukin-22. Expression of TLR5 on IECs regulates the composition and localization of the intestinal microbiota, preventing diseases associated with intestinal inflammation.
BACKGROUND & AIMS:Mice lacking the receptor Toll-like receptor 5 (TLR5-null mice), which recognizes flagellin, have an altered intestinal microbiota composition compared with wild-type mice; they develop low-grade inflammation and metabolic syndrome and are prone to colitis. The relative roles of intestinal epithelial cell (IEC) vs dendritic cell (DC) TLR5 in mediating these phenotypes are not clear; modification of intestinal microbiota composition has been reported to reflect animal husbandry practices rather than loss of TLR5. We generated mice with specific disruption of Tlr5 in IECs or DCs by using a breeding scheme that allows comparison with cohoused siblings as controls. METHODS: We generated C57BL/6 mice with LoxP sites flanking Tlr5. These mice were crossed with mice expressing Cre recombinase, regulated by the villin or CD11c promoters, to generate mice that lacked expression of TLR5 by IECs (TLR5(ΔIEC)) or DCs (TLR5(ΔDC)), respectively. Tlr5(fl/fl) siblings were used as controls. On weaning, mice were housed by sex and genotype or by sex only (genotypes cohoused). Mice were examined for basal phenotypes, including microbiota composition; we also analyzed responses to pathobiont challenge, administration of dextran sodium sulfate, and high-fat diets. RESULTS: Similar to previous findings from TLR5-null mice, TLR5(ΔIEC) mice had low-grade inflammation (mild splenomegaly, shortened colons, and increased fecal levels of lipocalin 2), metabolic syndrome, and an inability to clear pathobionts and were prone to developing colitis compared with their sibling controls under both housing conditions. Development of this inflammation in the TLR5(ΔIEC) mice was eliminated by administration of antibiotics and associated with alterations in localization of microbiota and levels of fecal lipopolysaccharide and flagellin. The composition of the microbiota clustered more closely according to genotype than housing. Loss of TLR5 from DCs did not associate with development of inflammation-associated phenotypes or alterations in the composition of the microbiota but resulted in complete loss of flagellin-induced production of interleukin-22. CONCLUSIONS: In mice, flagellin activation of TLR5 on DCs leads to production of interleukin-22. Expression of TLR5 on IECs regulates the composition and localization of the intestinal microbiota, preventing diseases associated with intestinal inflammation.
Authors: Chin Wen Png; Sara K Lindén; Kristen S Gilshenan; Erwin G Zoetendal; Chris S McSweeney; Lindsay I Sly; Michael A McGuckin; Timothy H J Florin Journal: Am J Gastroenterol Date: 2010-07-20 Impact factor: 10.864
Authors: Andrew T Gewirtz; Matam Vijay-Kumar; Steven R Brant; Richard H Duerr; Dan L Nicolae; Judy H Cho Journal: Am J Physiol Gastrointest Liver Physiol Date: 2006-01-26 Impact factor: 4.052
Authors: Malin E V Johansson; Mia Phillipson; Joel Petersson; Anna Velcich; Lena Holm; Gunnar C Hansson Journal: Proc Natl Acad Sci U S A Date: 2008-09-19 Impact factor: 11.205
Authors: Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz Journal: Science Date: 2010-03-04 Impact factor: 47.728
Authors: Matam Vijay-Kumar; Catherine J Sanders; Rebekah T Taylor; Amrita Kumar; Jesse D Aitken; Shanthi V Sitaraman; Andrew S Neish; Satoshi Uematsu; Shizuo Akira; Ifor R Williams; Andrew T Gewirtz Journal: J Clin Invest Date: 2007-12 Impact factor: 14.808
Authors: Carles Ubeda; Lauren Lipuma; Asia Gobourne; Agnes Viale; Ingrid Leiner; Michele Equinda; Raya Khanin; Eric G Pamer Journal: J Exp Med Date: 2012-07-23 Impact factor: 14.307
Authors: Benyue Zhang; Benoit Chassaing; Zhenda Shi; Robin Uchiyama; Zhan Zhang; Timothy L Denning; Sue E Crawford; Andrea J Pruijssers; Jason A Iskarpatyoti; Mary K Estes; Terence S Dermody; Wenjun Ouyang; Ifor R Williams; Matam Vijay-Kumar; Andrew T Gewirtz Journal: Science Date: 2014-11-14 Impact factor: 47.728
Authors: Agnieszka D Truax; Liang Chen; Jason W Tam; Ning Cheng; Hao Guo; A Alicia Koblansky; Wei-Chun Chou; Justin E Wilson; W June Brickey; Alex Petrucelli; Rongrong Liu; Daniel E Cooper; Mark J Koenigsknecht; Vincent B Young; Mihai G Netea; Rinke Stienstra; R Balfour Sartor; Stephanie A Montgomery; Rosalind A Coleman; Jenny P-Y Ting Journal: Cell Host Microbe Date: 2018-09-12 Impact factor: 21.023
Authors: Jun Zou; Benoit Chassaing; Vishal Singh; Michael Pellizzon; Matthew Ricci; Michael D Fythe; Matam Vijay Kumar; Andrew T Gewirtz Journal: Cell Host Microbe Date: 2017-12-21 Impact factor: 21.023
Authors: Miles Fuller; Medha Priyadarshini; Sean M Gibbons; Anthony R Angueira; Michael Brodsky; M Geoffrey Hayes; Petia Kovatcheva-Datchary; Fredrik Bäckhed; Jack A Gilbert; William L Lowe; Brian T Layden Journal: Am J Physiol Endocrinol Metab Date: 2015-09-22 Impact factor: 4.310